moderna
-
Moderna’s Covid-19 vaccine shows 94.5% efficacy against virus, says company
Scroll Staff
-
Coronavirus: US hopes to immunise 20 million in December, says vaccine programme head
Scroll Staff
-
Coronavirus: Vaccine makers Moderna and Pfizer reveal trial blueprint amid calls for transparency
Scroll Staff
-
Covid-19: US companies Moderna, Pfizer launch late-stage trials of vaccines
Scroll Staff
-
Coronavirus: US government doubles spending on vaccine candidate amid surge in cases
Scroll Staff
-
Coronavirus: Moderna to start final stage vaccine trial on July 27 after Phase I shows it is safe
Scroll Staff